Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

13 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression of cancer-related genes in human cells exposed to 60 Hz magnetic fields.
Loberg LI, Engdahl WR, Gauger JR, McCormick DL. Loberg LI, et al. Radiat Res. 2000 May;153(5 Pt 2):679-84. doi: 10.1667/0033-7587(2000)153[0679:eocrgi]2.0.co;2. Radiat Res. 2000. PMID: 10790292
Gene expression in human breast epithelial cells exposed to 60 Hz magnetic fields.
Loberg LI, Gauger JR, Buthod JL, Engdahl WR, McCormick DL. Loberg LI, et al. Carcinogenesis. 1999 Aug;20(8):1633-6. doi: 10.1093/carcin/20.8.1633. Carcinogenesis. 1999. PMID: 10426819
Ornithine decarboxylase activity in tissues from rats exposed to 60 Hz magnetic fields, including harmonic and transient field characteristics.
McDonald LJ, Loberg LI, McCormick DL, Gauger JR, Savage RE Jr, Zhu H, Lotz WG, Mandeville R, Owen RD, Cress LW, Desta AB. McDonald LJ, et al. Among authors: loberg li. Toxicol Mech Methods. 2003;13(1):31-8. doi: 10.1080/15376510309826. Toxicol Mech Methods. 2003. PMID: 20021180
Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonist.
Hudzik TJ, Basso A, Boyce-Rustay JM, Bracken W, Browman KE, Drescher K, Esbenshade TA, Loberg LI, Lynch JJ 3rd, Brioni JD. Hudzik TJ, et al. Among authors: loberg li. Psychopharmacology (Berl). 2013 Jul;228(2):187-97. doi: 10.1007/s00213-013-3027-7. Epub 2013 Feb 28. Psychopharmacology (Berl). 2013. PMID: 23455597
Characterization of ABBV-221, a Tumor-Selective EGFR-Targeting Antibody Drug Conjugate.
Phillips AC, Boghaert ER, Vaidya KS, Falls HD, Mitten MJ, DeVries PJ, Benatuil L, Hsieh CM, Meulbroek JA, Panchal SC, Buchanan FG, Durbin KR, Voorbach MJ, Reuter DR, Mudd SR, Loberg LI, Ralston SL, Cao D, Gan HK, Scott AM, Reilly EB. Phillips AC, et al. Among authors: loberg li. Mol Cancer Ther. 2018 Apr;17(4):795-805. doi: 10.1158/1535-7163.MCT-17-0710. Epub 2018 Feb 26. Mol Cancer Ther. 2018. PMID: 29483208 Free article.
Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.
Goss GD, Vokes EE, Gordon MS, Gandhi L, Papadopoulos KP, Rasco DW, Fischer JS, Chu KL, Ames WW, Mittapalli RK, Lee HJ, Zeng J, Roberts-Rapp LA, Loberg LI, Ansell PJ, Reilly EB, Ocampo CJ, Holen KD, Tolcher AW. Goss GD, et al. Among authors: loberg li. Cancer. 2018 May 15;124(10):2174-2183. doi: 10.1002/cncr.31304. Epub 2018 Mar 13. Cancer. 2018. PMID: 29533458 Free PMC article. Clinical Trial.
Challenges and opportunities for the future of monoclonal antibody development: Improving safety assessment and reducing animal use.
Sewell F, Chapman K, Couch J, Dempster M, Heidel S, Loberg L, Maier C, Maclachlan TK, Todd M, van der Laan JW. Sewell F, et al. MAbs. 2017 Jul;9(5):742-755. doi: 10.1080/19420862.2017.1324376. Epub 2017 May 5. MAbs. 2017. PMID: 28475417 Free PMC article.
13 results
Jump to page
Feedback